ASCEND BY NTHRYS
Research Abroad Products

Drug Designing Project Topics

Browse all focused areas across all project categories under this field.

Showing 217–228 of 280 project topics
Rapid Susceptibility Testing and Phenotypic Biomarker Discovery Suite
An automated diagnostic platform that performs rapid antibiotic susceptibility testing and identifies resistance biomarkers in 4-6 hours instead of traditional 24-48 hour methods. This enables contract research organizations and pharmaceutical companies to accelerate candidate validation and generate premium revenue through clinical lab partnerships.
Antibiotic Drug Discovery Biotechnology Click to view more details →
Structural Drug Design Platform for Resistance Evasion Engineering
A computational chemistry tool that redesigns antibiotic molecular scaffolds to evade known resistance mechanisms using structure-activity relationship modeling and synthetic biology workflows. This platform reduces lead optimization cycles by 40% and helps biotech firms maintain patent velocity and market exclusivity for next-generation antibiotics.
Antibiotic Drug Discovery Biotechnology Click to view more details →
Competitive Intelligence and Patent Landscape Analytics for Antibiotics Market
A specialized SaaS platform that tracks competitor drug pipelines, patent filings, clinical trial progress, and resistance breakpoints across the antibiotic market using real-time data aggregation. This subscription service generates recurring revenue while helping pharmaceutical and biotech firms optimize R&D investment and identify market gaps worth $5-15M annually.
Antibiotic Drug Discovery Biotechnology Click to view more details →
Formulation and Delivery Optimization Engine for Systemic and Topical Antibiotics
A digital platform combining pharmacokinetic modeling, bioavailability prediction, and stability testing protocols to optimize antibiotic formulations across oral, IV, and topical routes. This accelerates regulatory submissions and enables pharmaceutical companies to achieve faster FDA approvals and premium pricing through improved therapeutic efficacy data.
Antibiotic Drug Discovery Biotechnology Click to view more details →
Virtual Screening Against Biotechnology Drug Targets
Performing structure-based virtual screening of compound databases against validated protein drug targets using molecular docking for identifying novel hit compounds for experimental testing.
Computational Drug Discovery and Molecular Modelling Click to view more details →
Molecular Dynamics Simulation of Protein-Drug Binding
Running molecular dynamics simulations to study drug binding stability, allosteric communication, and protein flexibility for guiding drug optimization in biotechnology lead development.
Computational Drug Discovery and Molecular Modelling Click to view more details →
QSAR Model Development for Bioactivity Prediction
Building quantitative structure-activity relationship models from training datasets of bioactive compounds for predicting activity of new compound designs in drug discovery programs.
Computational Drug Discovery and Molecular Modelling Click to view more details →
De Novo Drug Design using Generative AI
Applying generative deep learning models to design novel drug-like molecules with desired pharmacological properties targeting biotechnology disease targets for drug discovery acceleration.
Computational Drug Discovery and Molecular Modelling Click to view more details →
AI-Powered Lead Optimization SaaS Platform for Drug Potency
Commercial SaaS platform that automates lead compound refinement using machine learning algorithms to predict and enhance drug potency, selectivity, and pharmacokinetic properties. Delivers accelerated drug candidate development timelines, reduced R&D costs by 30-40%, and enables pharmaceutical companies to reach IND-enabling studies faster.
Computational Drug Discovery and Molecular Modelling Click to view more details →
Protein Structure Prediction Software for Undruggable Target Identification
Enterprise software tool leveraging advanced deep learning models to predict 3D protein structures and identify cryptic binding pockets in historically undruggable targets. Generates new market opportunities by enabling therapeutic programs for previously intractable diseases and opens revenue streams through technology licensing to biotech partners.
Computational Drug Discovery and Molecular Modelling Click to view more details →
Real-Time Molecular Property Prediction Engine for Compound Filtering
Cloud-based computational tool that predicts ADME properties, toxicity profiles, and off-target effects in milliseconds for millions of chemical compounds simultaneously. Reduces compound library screening costs, minimizes late-stage development failures, and enables clients to achieve 2-3x faster hit-to-lead progression at lower expense.
Computational Drug Discovery and Molecular Modelling Click to view more details →
Binding Affinity Prediction Platform with Quantum-Classical Hybrid Computing
Proprietary platform combining quantum mechanics with classical molecular modeling to predict ligand-target binding affinities with superior accuracy for early drug discovery phases. Provides subscription-based revenue model while reducing false positives in virtual screening campaigns, enabling clients to prioritize candidates with 85%+ confidence before experimental validation.
Computational Drug Discovery and Molecular Modelling Click to view more details →